Cell therapy in kidney diseases: advancing treatments for renal regeneration

Amankeldi A Salybekov1, Aiman Kinzhebay1, Shuzo Kobayashi2

  • 1Qazaq Institute of Innovative Medicine, Regenerative Medicine Division, Cell and Gene Therapy Department, Astana, Kazakhstan.

Insights

Cell therapies show promise for kidney diseases like acute kidney injury (AKI) and chronic kidney disease (CKD). Research is advancing to overcome challenges in cell sourcing, delivery, and long-term outcomes for improved patient treatment.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Kidney diseases (AKI, CKD) are a major global health issue.
  • Diabetes and hypertension increase kidney disease risk.
  • Current treatments for kidney disease are limited.

Purpose of the Study:

  • To review the current state of cell therapies for kidney diseases.
  • To explore preclinical and clinical advancements in cell-based kidney treatments.
  • To identify challenges and future directions in kidney disease cell therapy.

Main Methods:

  • Comprehensive literature review of cell therapy research in kidney disease.
  • Analysis of preclinical studies and clinical trial data.
  • Evaluation of mechanisms of action for cell-based interventions.

Main Results:

  • Cell therapies demonstrate kidney protection via paracrine signaling, immune modulation, and tissue integration.
  • Positive outcomes observed in both acute kidney injury (AKI) and chronic kidney disease (CKD) models.
  • Cellular interventions offer potential for novel kidney disease management.

Conclusions:

  • Cell therapy is a promising avenue for treating kidney diseases.
  • Further research is needed to optimize cell sourcing, delivery, and long-term efficacy.
  • Enhancing cell function and refining delivery techniques are key to improving clinical outcomes.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
226
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K